Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I Trial
Annals of Neurology · 2026-11 · 100 (5) · 979-983
DOI: 10.1002/ana.78347 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Neurology, online erschienen am 08.09.2026. Verfasst von Koji Tanaka und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Factor Xa Inhibitors, Tomography, X-Ray Computed, Hematoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In this post hoc analysis of the ANNEXa‐I trial (n = 434), we evaluated non‐contrast computed tomography (NCCT) markers of hematoma expansion (HE) in factor Xa inhibitor (FXai) –associated intracerebral hemorrhage (ICH). At least one NCCT marker was present in 72.1%, and HE (≥12.5 mL or ≥ 35% increase in hematoma volume) occurred in 31.8%. Heterogeneous density, hypodensity, and the black hole sign were independently associated with HE. The effect of andexanet on HE was generally consistent across NCCT marker subgroups. These findings support the utility of NCCT markers for identifying patients at high risk of HE in FXai‐associated ICH. ANN NEUROL 2026;100:979–983
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Neurology, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Division of Neurology, Hamilton Health Sciences, McMaster University and Population Health Research Institute, Hamilton, Ontario, Canada.
- Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Division of Thrombosis & Hemostasis, Dresden University Clinic, Dresden, Germany.
ORCID-Profile: Umberto Pensato, Scott E Kasner, David J Seiffge, Georgios Tsivgoulis, Ashkan Shoamanesh
Zitieren
APA
Tanaka, K., Pensato, U., Alshamrani, M., Katsanos, A. H., Balali, P., Ray, S., Kasner, S. E., Beyer-Westendorf, J., Toni, D., Seiffge, D. J., Molina, C., Tanne, D., Członkowska, A., Lindgren, A. G., Bereczki, D., Sandset, E. C., Tsivgoulis, G., Christensen, H., Coutinho, J. M., …, & Demchuk, A. M. (2026). Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I Trial. Annals of Neurology, 100(5), 979-983. https://doi.org/10.1002/ana.78347
Vancouver
Tanaka K, Pensato U, Alshamrani M, Katsanos AH, Balali P, Ray S, et al. Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I Trial. Annals of Neurology. 2026;100(5):979-983. doi:10.1002/ana.78347
BibTeX
@article{Tanaka2026,
author = {Tanaka, Koji and Pensato, Umberto and Alshamrani, Mohamed and Katsanos, Aristeidis H and Balali, Pargol and Ray, Sucharita and Kasner, Scott E and Beyer-Westendorf, Jan and Toni, Danilo and Seiffge, David J and Molina, Carlos and Tanne, David and Członkowska, Anna and Lindgren, Arne G and Bereczki, Daniel and Sandset, Else C and Tsivgoulis, Georgios and Christensen, Hanne and Coutinho, Jonathan M and Verhamme, Peter and Amarenco, Pierre and Lemmens, Robin and Veltkamp, Roland and Middeldorp, Saskia and Robinson, Thompson and Milling, Truman J and Lang, Wilfried and Tedium-Cruz, Vitor and Crowther, Mark and Xu, Lizhen and Knutsson, Mikael and Ladenvall, Per and Eikelboom, John W and Sharma, Mukul and Shoamanesh, Ashkan and Demchuk, Andrew M},
title = {Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I Trial},
journal = {Annals of Neurology},
year = {2026},
volume = {100},
number = {5},
pages = {979--983},
doi = {10.1002/ana.78347}
}
EUVIMED